z-logo
open-access-imgOpen Access
ERK1/2 and p38 MAPKs Are Complementarily Involved in Estradiol 17ß-d-Glucuronide-Induced Cholestasis: Crosstalk with cPKC and PI3K
Author(s) -
Andrea C. Boaglio,
Andrés E. Zucchetti,
Flavia D. Toledo,
Ismael R. Barosso,
Enrique J. Sánchez Pozzi,
Fernando A. Crocenzi,
Marcelo G. Roma
Publication year - 2012
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0049255
Subject(s) - multidrug resistance associated protein 2 , wortmannin , internalization , cholestasis , bile salt export pump , kinase , p38 mitogen activated protein kinases , mapk/erk pathway , microbiology and biotechnology , biology , endocrinology , chemistry , medicine , biochemistry , transporter , atp binding cassette transporter , receptor , phosphatidylinositol , gene
Objective The endogenous, cholestatic metabolite estradiol 17ß- d -glucuronide (E 2 17G) induces endocytic internalization of the canalicular transporters relevant to bile formation, Bsep and Mrp2. We evaluated here whether MAPKs are involved in this effect. Design ERK1/2, JNK1/2, and p38 MAPK activation was assessed by the increase in their phosphorylation status. Hepatocanalicular function was evaluated in isolated rat hepatocyte couplets (IRHCs) by quantifying the apical secretion of fluorescent Bsep and Mrp2 substrates, and in isolated, perfused rat livers (IPRLs), using taurocholate and 2,4-dinitrophenyl- S -glutathione, respectively. Protein kinase participation in E 2 17G-induced secretory failure was assessed by co-administering selective inhibitors. Internalization of Bsep/Mrp2 was assessed by confocal microscopy and image analysis. Results E 2 17G activated all kinds of MAPKs. The PI3K inhibitor wortmannin prevented ERK1/2 activation, whereas the cPKC inhibitor Gö6976 prevented p38 activation, suggesting that ERK1/2 and p38 are downstream of PI3K and cPKC, respectively. The p38 inhibitor SB203580 and the ERK1/2 inhibitor PD98059, but not the JNK1/2 inhibitor SP600125, partially prevented E 2 17G-induced changes in transporter activity and localization in IRHCs. p38 and ERK1/2 co-inhibition resulted in additive protection, suggesting complementary involvement of these MAPKs. In IPRLs, E 2 17G induced endocytosis of canalicular transporters and a rapid and sustained decrease in bile flow and biliary excretion of Bsep/Mrp2 substrates. p38 inhibition prevented this initial decay, and the internalization of Bsep/Mrp2. Contrarily, ERK1/2 inhibition accelerated the recovery of biliary secretion and the canalicular reinsertion of Bsep/Mrp2. Conclusions cPKC/p38 MAPK and PI3K/ERK1/2 signalling pathways participate complementarily in E 2 17G-induced cholestasis, through internalization and sustained intracellular retention of canalicular transporters, respectively.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom